To validate differential expression of two candidate markers at the protein level, we performed immunohistochemistry to detect CD24 antigen and SPARCL-1 protein in a pair of slides representing a benign and malignant tumour (Figure 3). The gene discussed is SPARCL1; the disease is neoplasm.